Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-25-047224
Filing Date
2025-10-29
Accepted
2025-10-29 17:59:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4139
  Complete submission text file 0001628280-25-047224.txt   5681
Mailing Address C/O UCSF, 1450 3RD STREET RM HD-371 SAN FRANCISCO CA 941439001
Business Address
MCCORMICK FRANK (Reporting) CIK: 0001257809 (see all company filings)

Type: 144

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Subject) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38959 | Film No.: 251431402
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)